Overview
The WRW4, Formyl Peptide Receptor-Like 1 (FPRL1) Antagonist is a powerful tool for researchers exploring the dynamics of chemoattractant receptors in the immune system and neurological studies. This synthetic peptide inhibits the binding of WKYMVm, an FPRL1 agonist, to its receptor, providing valuable insights into inflammatory responses and neurodegenerative diseases. With its specific action on phagocytic cells found in peripheral blood and the brain, WRW4 is essential for studies in cell signaling related to host defense mechanisms.
Key Features
- Inhibits binding of FPRL1 agonist WKYMVm
- Targets phagocytic cells in peripheral blood and brain
- Supports research on inflammatory responses and neurodegeneration
- Available in a 1 mg format for convenience
- Manufactured with high-quality standards
Specifications
| Item | Details |
|---|---|
| Product Name | WRW4, Formyl Peptide Receptor-Like 1 (FPRL1) Antagonist |
| Category | Peptides |
| Size | 1 mg |
| Storage Conditions | Store at -20°C |
FAQ
What is the role of FPRL1 in the body?
FPRL1 is a classical chemoattractant receptor involved in the immune response, expressed primarily in phagocytic cells. It plays a crucial role in guiding immune cells to sites of inflammation.
How can I use WRW4 in my experiments?
WRW4 can be incorporated into studies focusing on cell signaling and inflammatory pathways, especially when examining the effects of FPRL1 activation or inhibition.
Where can I find more related peptides?
You can explore our full selection of peptides, including other labeling options, to enhance your research by visiting our peptides catalog.
Enhance your research with the WRW4, Formyl Peptide Receptor-Like 1 (FPRL1) Antagonist. Buy now to take your studies in inflammatory responses and neurodegenerative disorders to the next level.




Reviews
There are no reviews yet.